Vasculitis and rapidly progressive glomerulonephritis in the elderly

Postgraduate Medical Journal

Volumn 72, Issue 843, 1996, Pages 41-44

  Higgins, R M ^a,c   Goldsmith, D J A ^b   Connolly, J ^a   Scoble, J E ^a   Hendry, B M ^a   Ackrill, P ^b   Yenning, M C ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

^c WALSGRAVE HOSPITAL   (United Kingdom)

Author keywords

Cyclophosphamide; Elderly patients; Glomerulonephritis; Vasculitis

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

AGED; ARTICLE; DIALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; REMISSION; SURVIVAL; TREATMENT OUTCOME; VASCULITIS;

EID: 0030029372     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.72.843.41     Document Type: Article

References (16)

1. Serra A, Cameron JS, Turner DR, et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med 1984; 53: 181-207.
2. Coward RA, Hamdy NAT, Shortland JS, Brown CB. Renal micropolyaneritis: a treatable condition. Nephrol Dial Transplant 1986; 1: 31-7.
3. Adu D, Howie AJ, Scott DGI, Bacon PA, McGonigle RJS, Michael J. Polyarteritis and the kidney. Q J Med 1987; 62: 221-37.
4. Hind CRK, Paraskevakou H, Lockwood CM, Evans DJ, Peters DK, Rees AJ. Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis. Lancet 1983; i: 263-5.
5. Haubitz M, Frei U, Rother U, Brunkhorst R, Koch KM. Cyclophosphamide pulse therapy in Wegener's granulomatosis. Nephrol Dial Transplant 1991; 6: 531-5.
6. Stavrou P, Deutsch J, Rene C, Laws DE, Luqmani RA, Murray PI. Ocular manifestations of classical and limited Wegener's granulomatosis. Q J Med 1993; 86: 719-25.
7. Bindi P, Mougenot B, Mentre F, et al. Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med 1993; 86: 55-68.
8. Garrett PJ, Dewhurst AG, Morgan LS, Dathan JR. Renal disease associated with circulating antineutrophil cytoplasm antibody. Q J Med 1992; 85: 731-49.
9. Geerlings W. Annual report on the management of renal failure in Europe. Presented to the European Dialysis and Transplant Association, Glasgow, 1992.
10. Fuiano G, Cameron JS, Raftery M, Hartley JR, Williams DG, Ogg CS. Improved prognosis of renal microscopic polyarteritis in recent years. Nephrol Dial Transplant 1988; 3:383-91.
11. Venning MC, Quinn A, Broomhead V, Bird AG. Antibodies directed against neutrophils (cANCA and pANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med 1990; 77: 1287-96.
12. Garrett PJ, Dewhurst AG, Morgan LS, Mason JC, Dathan JR. Renal disease associated with circulating antineutrophil cytoplasm antibody. Q J Med 1992; 85: 731-49.
13. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.
14. Gordon M, Luqmani RA, Adu D, et al. Relapses in patients with a systemic vasculitis. Q J Med 1993; 86: 779-89.
15. Balow JE. Renal vasculitis. Kidney Int 1985; 27: 954-64.
16. Heilmar RL, Offord KP, Holley KE, Velosa JA. Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis 1987; 9: 98-107.